In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price ...
CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback